Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Massive Polycystic Liver in ADPKD
NCT01680250Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT01680250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680250.